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Abstract.  Antibody-induced degradation and chemical 
cross-linking experiments have been carried out to as- 
sess the nature of the interaction between the two 
asialoglycoprotein-receptor polypeptides, H1  and H2, 
synthesized in HepG2 cells.  Incubation of HepG2 cell 
monolayers with anti-H1  antibody caused a  specific 
and equal loss of both H1  and H2 polypeptides.  The 
same result was obtained with anti-H2 antibody. Con- 
trol serum did not affect the level of H1  or H2 nor did 
anti-H1  or anti-H2 antibodies affect the level of the 
transferrin receptor. The chemical cross-linking re- 
agent,  difluorodinitrobenzene, has been used to dem- 
onstrate that H1  can be cross-linked to H2  in HepG2 
cell microsomal membranes.  Dimer and trimer species 
with apparent molecular masses  of 93 and  148 kD, 
respectively, were readily observed upon chemical 
cross-linking and some dimers and trimers  were im- 
munoreactive with both anti-H1  and anti-H2 antibod- 
ies.  The putative trimer, possibly two H1  and one H2 
molecules,  is a  minimum estimate of the true size of 
the asialoglycoprotein receptor in intact HepG2 cell, 
and it is possible that larger hetero-oligomeric forms 
of the receptor exist.  The results of both types of ex- 
periments indicate that H1  and H2  form an oligomeric 
complex in HepG2 cells and thus,  both polypeptides 
constitute the human asialoglycoprotein receptor. 
T 
HE asialoglycoprotein receptor (ASGP-R) ~ is a liver- 
specific membrane glycoprotein that binds to terminal 
galactose and N-acetylgalactosamine residues on se- 
rum glycoproteins (for review, 2, 6). This receptor has been 
studied extensively in rabbit liver, rat liver, and human liver, 
as well as the human hepatoma cell line HepG2. In each of 
these species, the receptor activity appears to consist of mul- 
tiple polypeptide chains. In rabbit liver, 40- and 48-kD pro- 
teins have been observed (12, 13). In rat liver, three polypep- 
tide species of 41.5, 49,  and 54 kD have been characterized 
(7, 22, 28). In human liver and in HepG2 cells (3, 23), a sin- 
gle polypeptide of 46 kD has been observed; more recently, 
a 50-kD protein has also been characterized (5). In all cases, 
the higher molecular mass species are less abundant than the 
lower molecular mass polypeptides. Protein sequencing (7) 
and cDNA cloning (11, 18, 26, 27) of the rat and human recep- 
tors has revealed that the polypeptides are distinct from each 
other. The human cDNAs and their protein products are re- 
ferred to  as  H1  and  H2  (26)  while the  rat hepatic  lectin 
(RHL) cDNAs are referred to as RHL-1 and RHL-2/3 (7). 
RHL-1  is  more homologous to H1  than  to RHL-2/3, and 
RHL-2/3 is more homologous to H2 than to RHL-1 (18, 26). 
RHL-2/3 is so named because it consists of two polypeptide 
species of 49 and 54 kD,  respectively; the increment in ap- 
1, Abbreviations  used in this paper:  ASGP-R, asialoglycoprotein receptor; 
DFDNB,  1,5-difluoro-2,4 dinitrobenzene; DTSP, dithiobis (succinimidyl) 
propionate; RHL,  rat hepatic lectin. 
parent  molecular mass  has  been  attributed  to  differential 
oligosaccharide modifications (10). 
The fact that the proteins are distinct molecules raised an 
important question about the structure and function of the 
ASGP-R.  Do the two proteins represent subpopulations of 
ASGP-R(s) or do they associate to form a multicomponent 
receptor? Transfection of the two cDNAs into heterologous 
cell lines has been used to ascertain the role of the individual 
polypeptide species in cellular ASGP-R activity. McPhaul 
and Berg (17) have shown that expression of both rat ASGP- 
receptor cDNAs, RHL-1 and RHL-2/3, is required to enable 
rat hepatoma cells to accumulate fluorescein-labeled asialo- 
orosomucoid in the lysosomes. In this laboratory, Shia and 
Lodish (submitted for publication) have found that both of 
the human ASGP-R cDNAs,  H1  and  H2,  are required to 
reconstitute ASGP-R binding activity at the cell surface of 
murine 3T3 cells. 
In the present study, we used two different experimental 
protocols to show that H1 and H2 polypeptides are present 
in an oligomeric complex in the human hepatoma cell line 
HepG2. First, we examined the fate of ill and H2 after incu- 
bation of HepG2 cell monolayers with anti-H1, anti-H2, or 
control  serum.  Many  cell  surface  receptors  and  macro- 
molecules have been shown to undergo "capping" and disap- 
pearance  from the  plasma  membrane upon  incubation of 
cells with specific antireceptor antibodies (1, 8,  19, 23, 29). 
This is thought to occur because the polyclonal antibodies 
cause extensive cross-linking of the receptors at the cell sur- 
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somes, or in some cases, a "prelysosomal compartment" (31) 
for degradation. Incubation of HepG2 cells with an antibody 
specific for H1 caused an equal loss of both H1 and H2 poly- 
peptides, and conversely, incubation of HepG2 cells with an 
antibody specific for H2 caused an equal loss of both poly- 
peptides. 
The second approach was to determine whether the poly- 
peptides could be specifically cross-linked to each other by 
homobifunctional cross-linking reagents. Since we are most 
interested in the structure of the receptor in the membrane 
and we know that the interaction between the two polypep- 
tides  is  difficult to detect once the proteins are detergent- 
solubilized (5),  the coss-linking experiments were carried 
out  on  microsomal  membranes.  After  chemical  cross- 
linking of microsomal membranes, solubilization with deter- 
gent, and immunoadsorption with anti-H1 or anti-H2 anti- 
body,  molecular mass  species  consistent with  dimer  and 
trimer  forms  of the  receptor were  observed.  Using  two 
different immunodetection protocols we have demonstrated 
that some of the higher molecular mass species formed by 
chemical cross-linking react with both anti-H1 and anti-H2 
antibodies. Thus, although we do not know the stoichiome- 
try, each species must contain both HI and H2 polypeptides. 
Our results, together with the results of H1  and H2 eDNA 
transfection experiments  (Shia  and  Lodish,  submitted  for 
publication), indicate that the human ASGP-R is an oligo- 
merle complex made up of two distinct polypeptide species- 
H1  and H2. 
Materials and Methods 
Materials 
Materials were obtained from the following sources:  L-[35S]cTsteine (spe- 
cific  radioactivity,  983  Ci/mmol),  New  England  Nuclear,  Boston,  MA; 
~25I-labeled Protein-A (specific activity, >30 mCi/mg) and  ~4C-methylated 
protein standards, Amersham Corp., Arlington Heights, IL; keyhole limpet 
hemocyanin,  Calbiochem  Behring  Corp.,  San  Diego,  CA;  Protein-A- 
Sepharose CI-4B, Sephadex G-25-150,  oxidized glutathione, and aprotinin, 
Sigma Chemical Co.,  St. Louis, MO;  sulfosuccinimidyl 4-(N-maleimido- 
methyl)  cyclohexane-l-carboxylate;  dithiobis  (succinimidyl)  propionate 
(DTSP);  1,5-difluoro-2,4-dinitrobenzene (DFDNB); and BCA* protein as- 
say  reagent,  Pierce  Chemical  Co.,  Rockford,  IL;  nitrocellulose  filters, 
Schleicher &  Schuell Inc.,  Keene,  NH;  goat anti-rabbit IgG, Boehringer 
Mannheim Diagnostics, Houston, TX; 2,5 diphenyloxazole, National Diag- 
nostics Inc., Somerville, N J; fetal calf serum, dialyzed fetal calf serum, Ea- 
gle's  minimal  essential  medium,  Dulbecco's  modified  Eagle's  medium, 
glutamine (100X),  penicillin/streptomycin (100X),  and Freund's complete 
and incomplete adjuvunt, Gibco Laboratories, Grand Island, NY. Anti-hu- 
man  transferrin receptor  antibody  was  kindly  provided  by  Dr.  Caroline 
Enns, Syracuse University, Syracuse, NY. All other chemicals were reagent 
grade. 
Preparation of  Antipeptide Antibodies 
15- and 12-amino acid peptides corresponding to the carboxy termini of H1 
and H2, respectively, were synthesized by Dr.  Peter Kim, The Whitehead 
Institute,  Cambridge,  MA  by  solid-phase  synthesis (4) on an automated 
430A peptide synthesizer from Applied Biosystems, Inc., Foster City, CA. 
In addition, a  10-amino acid peptide corresponding to the unique cytoplas- 
mic domain of H2 was synthesized. The peptides were coupled to the carrier 
protein, keyhole limpet hemocyanin, using the chemical cross-linking re- 
agent sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-l-carboxylate 
following the procedure of Green et al. (9). Rabbits were immunized with 
the peptide conjugates in Freund's complete adjuvunt and boosted every 2-3 
wk for up to 3 mo. The specificity of the antisera was tested by their ability 
to immunoadsorb  [35S]methionine-labeled translation products of HI  and 
H2 as previously described (5).  The anti-H1-COOH  serum is specific for 
Figure 1. Specificity  of anti-H1  and anti-H2 antibodies.  Lanes 1-4 
and 10 contained  HI translation products and lanes 5-8,  9, and// 
contained  H2 translation products. Aliquots  from the total transla- 
tion reactions (lanes  1, 5, and 9) and immunoadsorbed  translation 
products  (lanes 2  and  6,  control  rabbit  serum;  lanes 3  and  7, 
anti-H2 cytoplasmic  insert serum;  lanes 4  and 8,  anti-HI-COOH; 
and lanes 10 and//, anti-H2-COOH)  were subjected to SDS-PAGE. 
For immunoadsorption,  the translation products were incubated in 
50 ~tl of immunoadsorption  buffer with 2  lal of the designated an- 
tiserum  for  2  h  on  ice.  The  Protein  A-Sepharose  pellets  were 
washed twice with immunoadsorption buffer and once with  10 mM 
Tris, pH 8.0, 0.2%  Nonidet P-40. Lanes 5-8 and lanes 9 and//rep- 
resent separate H2 translation reactions. The migration of molecu- 
lar mass  standards  (kD)  is  indicated  on the left. 
HI alone and the anti-H2-COOH and anti-H2 cytoplasmic insert sera are 
specific for H2 (Fig.  1). The anti-H1-COOH and the anti-H2 cytoplasmic 
insert antibodies were used for all immunoadsorption reactions presented 
in this paper. 
Cell Culture 
The growth of the human hepatoma cell line HepG2 in Eagle's minimal es- 
sential medium,  10%  fetal calf serum,  100 U/ml penicillin, and  100 p.g/ 
ml streptomycin was  carried out as  described  (14).  The cell  monolayers 
were trypsinized and split  1/10 into 60-ram petri dishes 4-5 d before each 
experiment. 
Metabolic Labeling of  HepG2 Cells 
Subconfluent (75-90%) monolayers were rinsed twice with DME devoid of 
cysteine but supplemented with 10% dialyzed fetal calf serum, 2 mM gluta- 
mine,  100 U/ml  penicillin, and  100 I.tg/ml streptomycin (cys-free DME). 
The cells were preincubated in 2  ml of cys-free DME for 20 min at 37~ 
rinsed again with cys-free DME,  and then labeled overnight with [35S]cys- 
teine (200-300 IxCi/ml) in 1.0 ml of cys-free DME supplemented with 5 IXM 
nonradioactive cysteine. 
Immunoadsorption of  ill and H2 
All  steps  were  carried  out  at  0-4~  unless  otherwise  noted.  Total 
microsomal  membrane  proteins  were  solubilized  and  subjected  to  im- 
munoadsorption  with anti-HI  or anti-H2  serum as previously described 
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Sepharose, denatured by boiling for 5 min in 60 p,l of 125 mM Tris pH 6.8, 
2% SDS, 20% glycerol, 2% 2-mercaptoethanol, and 0.002% bromophenol 
blue (SDS-gel sample buffer), and subjected to SDS-10%-PAGE (15). Fluo- 
rography using 20%, 2,5 diphenyloxazole in acetic acid (wt/wt) was carried 
out as described (25).  The dried gels were exposed to pre-flashed Kodak 
XAR or SB-5 film at  -70~ 
Incubation of  HepG2 Cells with Anti-H1 and 
Anti-H2 Antibodies 
The cell monolayers were washed once with 2  ml PBS, 5-mM EDTA for 
<1 min at 4~  and then two times with 3 ml of MEM medium (without se- 
rum), 2  mM glutamine, and 20 mM Hepes, pH 7.4 (MEM/Hepes).  The 
cells were then incubated with 0.2 ml of control serum, anti-H1-COOH se- 
rum, or anti-H2-COOH serum in a total volume of 0.8 ml of MEM/Hepes 
for 90 rain at 37~  The monolayers were rinsed again three times with 
MEM/Hepes and then further incubated in the presence or absence of 35 
txg of affinity-purified goat anti-rabbit IgG in a total volume of 0.75 ml at 
37~  for various lengths of time.  At the end of the incubation, the cell 
monolayers were rinsed three times with ice-cold PBS and the solubilized 
microsomal membranes were prepared as described (5).  To denature any 
IgG molecules that might have been present, the samples were adjusted to 
1% SDS and 2 mM dithiothreitol and boiled for 5 min. The samples were 
diluted approximately  sixfold  into PBS,  1%  Triton  X-100, 0.5%  sodium 
deoxycholate,  2.5  mg/ml  bovine  serum  albumin  (immunoadsorption 
buffer), and adjusted to 2  mM oxidized glutathione. The diluted samples 
were incubated with 75  [.tl of a  1:1  suspension of Protein-A-Sepharose in 
PBS, 0.02% sodium azide for 1 h at4~  with constant rotation. The Protein- 
A-Sepharose was sedimented by brief centrifugation. The supernatant was 
divided into three equal parts (0.45 ml) and subjected to immunoadsorption 
with  10 I.tl of control serum, anti-H1-COOH serum, or anti-H2 serum at 
0-4~  for 14 h. The aliquot taken was adjusted so that equal protein (~85 
I.tg) was subjected to immunoadsorption for each experimental condition; 
this corrects for slight differences in recovery of cell protein from each petri 
dish. The antigen-antibody complexes, adsorbed to 25 ~tl of packed Protein- 
A-Sepharose, were washed two times with 1 ml of immunoadsorption buffer 
and two times with 1 ml of 10 mM Tris, pH 8.0, 0.2%  Nonidet-40 and then 
subjected to SDS-PAGE and fluorography. 
Chemical Cross-linking 
Solutions (100X) of DFDNB and DTSP in absolute ethanol were made fresh 
for each experiment.  Total  microsomal membranes were  isolated as de- 
scribed (5)  and resuspended in 0.1  M  NaPO4 pH 7.0. The cross-linking 
reactions were carried out for 1 h at room temperature and then quenched 
by adjusting the samples to 2 mM glycine. Membrane proteins were solubi- 
lized by addition of Triton X-100 and sodium deoxycholate to 1% and 0.5%, 
respectively, and incubation of ice for  1 h. The samples were centrifuged 
at 12,000 g for 20 min. and the supernatants subjected to immunoadsorption 
as described above. 
lmmunoblot with Anti-HI Antibody 
The samples were subjected to electrophoresis on a 5-10% polyacrylamide 
gradient SDS-gel and then transferred to a  nitrocellulose membrane. The 
membrane was incubated with a 1:100 dilution of anti-H1 antibody, and then 
with  125I-labeled Protein  A  following an established protocol  (20).  1251- 
Protein A--labeled  bands were visualized by autoradiography at  -70~ 
Two-Dimensional-SDS-PAGE (4-/- 2-Mercaptoethanol) 
Immunoadsorbed proteins were loaded on a 7.5 % polyacrylamide tube gel 
(0.3  ￿  15 cm) and subjected to electrophoresis as described (15). The tube 
gel was then equilibrated in  10 ml of SDS-gel sample buffer including 2% 
2-mercaptoethanol. The tube was layered on the top of a  standard  10%- 
polyacrylamide SDS gel, secured with agarose, and subjected to electropho- 
resis as described (15). 
Protein Determination 
The Pierce BCA* protein assay reagent was used to determine protein con- 
centrations  following  the  manufacturer's protocol.  BSA  was  used  as  a 
standard. 
Densitometry 
Fluorograms  were  scanned (three  times per  lane)  using an  LKB  2202 
Ultroscan  laser  densitometer  with  an  LKB  recording  integrator  (LKP 
Producter, Bromma, Sweden). 
Results 
Specificity of  Anti-H1 and Anti-H2 Antibodies 
The human ASGP-R polypeptides, H1 and H2, are 58 % ho- 
mologous at the amino acid sequence level (26) and have 
many structural features in common. Both polypeptides have 
an amino-terminal cytoplasmic domain, a single membrane- 
spanning domain, and a large exoplasmic carboxy-terminal 
domain. The unique features of H2 are an apparent insertion 
of 18 amino acids relative to H1  in its  NH:-terminal cyto- 
plasmic domain and a third asparagine-linked oligosaccha- 
ride near the COOH terminus.  The proteins also differ in 
amino acid sequences at their extreme COOH termini. The 
last 13 amino acids of H1 and 10 amino acids of H2 are dis- 
tinct (HI is three amino acids "longer" than H2). We gener- 
ated  antipeptide  antibodies  directed  against  the  COOH- 
terminal domains of each polypeptide, as well as the unique 
cytoplasmic domain of H2. The specificity of these antisera 
was  examined  by  testing  their  ability  to  immunoadsorb 
[35S]methionine-labeled  translation products of H1  and H2 
synthesized  in  the presence of dog  pancreas  microsomes 
(Fig. 1). The anti-H1 antiserum will recognize only H1 poly- 
peptide (lane 4), and not H2 (lane 8), while the anti-H2 an- 
tisera will recognize only H2 polypeptide (lanes 7 and//), 
and not H1 (lanes 3 and 10). The polypeptides were not ad- 
sorbed by control rabbit serum (lanes 2 and 6).  Since the 
COOH-terminal  domains  of H1  and  H2  are  exoplasmic, 
anti-COOH antibodies are able to bind to receptors on the 
plasma  membrane and  thus,  they provide useful  tools for 
studying the interaction of H1 and H2 in intact HepG2 cells. 
A n tibody-induced  Degradation 
The fate of H1  and  H2  polypeptides was  examined after 
incubation  of HepG2  cells  with  anti-H1-COOH  or  anti- 
H2-COOH  serum  and  then  further  incubation  with  goat 
anti-rabbit IgG (Fig. 2). HepG2 monolayers, metabolically 
labeled with  [35S]cysteine for 21  h,  were incubated for 90 
min at 37~  in the presence of control serum (A and B, lanes 
1, 4, and 7), anti-H1-COOH serum (A and B, lanes 2, 5, and 
8),  anti-H2-COOH  serum  (A  and B,  lanes  3,  6,  and  9), 
buffer alone (A and  B,  lane  10), or anti-H1  and  anti-H2 
COOH together (A and B, lane//). The unbound IgGs and 
serum proteins were rinsed off and the cell monolayers were 
further incubated with goat anti-rabbit IgG at 37~  for 0 h 
(A and B,  lanes 1-3),  1 h (A and B,  lanes 4-6), or 2 h (A 
and B, lanes 7-11  ). Solubilized membrane proteins were iso- 
lated and denatured by boiling in SDS and dithiothreitol and 
subjected  to  immunoabsorption  with  anti-H1-COOH  (A), 
anti-H2 (B), or control serum (data not shown). The denatu- 
ration  step  was  sufficient  to  inactivate  any  anti-H1  or 
anti-H2 molecules in the membrane extract because no H1 
or  H2  was  observed  upon  subsequent  immunoadsorption 
with control serum. 
In this experiment, anti-H1 antibody caused a 75-80% de- 
crease in immunoprecipitable H1 and H2 after a 1-h incuba- 
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of H1 and H2 polypeptides. HepG2 cell 
monolayers were incubated with 200 ~tl 
of control (lanes 1, 4, and  7),  anti-H1 
(lanes 2, 5, 8, and//), or anti-H2 (lanes 
3,  6,  9,  and  //)  serum  or with buffer 
alone (lane I0) in a final volume of 0.8 
ml for 90 min at 37~  The cells were 
further  incubated  with  35  ~tg of goat 
anti-rabbit  IgG antibody  for 0  (lanes 
1-3),  1 (lanes 4-6), or 2 (lanes 7-11 ) h. 
Cells  were lysed and prepared  for im- 
munoadsorption  with  anti-HI  (A)  or 
anti-H2  (B)  antibody  as described  in 
Materials  and  Methods. The  fluoro- 
graph shown in A was exposed for 22 h 
whereas  the  fluorograph  in  B was ex- 
posed for 92 h. 
tion with goat anti-rabbit IgG (lane 5).  90% of each poly- 
peptide had disappeared by 2 h (lane 8). Anti-H2 antibody 
caused a 40% loss of HI and H2 polypeptides by 1 h (lane 
6) and a 70% loss by 2 h (lane 9).  Loss of H1 and H2 poly- 
peptides after incubation with both anti-H1 and anti-H2 se- 
rum (A and B, lane//) was equivalent to that observed with 
anti-H1 serum alone (A and B, lane 8). Goat anti-rabbit IgG 
alone had no effect on HI and H2 (A and B, lane 10) but it 
was  required  to  obtain  the  antibody-induced  degradation 
seen here (data not shown). This is probably due to the fact 
that the antipeptide antibodies are directed against single epi- 
topes  on  the  proteins  and  therefore  may  not  cross-link 
sufficiently.  Similarly,  some monoclonal antibodies do not 
cause the extensive cross-linking necessary to bring about 
degradation  (1)  and  second  antibodies  have been  used  to 
achieve this  effect (19).  Anti-H1-COOH,  anti-H2-COOH, 
and control serum did not affect the level of biosynthetically 
labeled transferrin receptor in these HepG2 cells (data not 
shown) indicating that the antibody-induced degradation of 
H1  and H2 was specific. 
Table I  summarizes the  results  of four  separate experi- 
ments carried out as described in Fig. 2. It is clear that the 
effect of anti-H1-COOH on the level of HI and H2 polypep- 
tides is nearly identical and conversely, the effect of anti-H2- 
COOH on H1 and H2 is very similar. The extent of degrada- 
tion due to anti-H2-COOH antibody was not as great as with 
anti-H1-COOH, although it was identical for both H1 and H2 
polypeptides. Increasing the amount of anti-H2-COOH anti- 
body did not result in greater degradation (data not shown). 
Although we attribute the loss of HI and H2 polypeptides 
to extensive cross-linking by the antibodies and subsequent 
delivery to the lysosomes, which is usually the case (1), we 
have not rigorously shown that the loss of antigens is due to 
degradation in the lysosomes. Gartung et al.  (8) found that 
anti-mannose-6-phosphate  receptor  antibodies  caused  the 
215-kD receptor to become detergent insoluble and thus, the 
degradation was only apparent. Furthermore, Schwartz et al. 
(21)  reported  that  antibody-induced  degradation  of  the 
ASGP-R occurred in a  "prelysosomal compartment" They 
found, however, that the polyclonal antibody raised against 
the purified human liver ASGP-R caused a net loss of antigen 
from HepG2 cells and very little receptor had become deter- 
gent insoluble. The important point of the results presented 
in  Fig.  2  and Table I  is that both antibodies had the same 
effect on H1 and H2 polypeptides indicating that the two pro- 
teins are associated in a complex at the plasma membrane. 
Table L Effect of  Anti-H1-COOH, Anti-H2-COOH, and Control Serum on HepG2 Cell HI and H2 
Goat anti-rabbit 
Anti-Hl  Anti-H2  Control  IgG alone 
Exp.  no.  Time  H1  H2  HI  H2  HI  H2  HI  H2 
1. 
2. 
3. 
min  % 
0  100  100  100  100  100  100  -  - 
90  26  30  52  51  120  122  90  107 
0  100  100  100  100  100  100  -  - 
60  26  18  60  49  105  79  -  - 
120  10  10  43  30  88  73  98  83 
0  100  100  100  100  100  100  -  - 
45  67  53  64  62  107  110  -  - 
90  30  49  -  55  102  89  -  - 
150  16  13  54  47  100  62  80  62 
After incubation with anti-H1, anti-H2, or control serum, cells were incubated with 30-35  I-tg of goat anti-rabbit IgG at 37~  The amounts of [sSS]cysteine- 
labeled H1 and H2 polypeptides were determined by densitometric scanning of each fluorograph. Experiment 2  is the average of two separate experiments.  -, 
not determined. 
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proteins with DTSP and immunoadsorption of H1 
and  H2.  Microsomal  membranes  were  isolated 
from HepG2 cells labeled with  [35S]cysteine for 
20 h, and cross-linked with 0 (lanes I  and 2), 0.05 
mM (lanes 3 and 4), 0.075 mM (lanes 5  and 6), 
and 0.10 mM (lanes  7 and 8) DTSP as described 
in Materials and Methods. Solubilized membrane 
proteins were subjected to immunoadsorption with 
anti-HI (lanes 1, 3, 5, and 7) or anti-H2 (lanes 2, 
4,  6,  and  8)  serum  and  then  SDS-PAGE  and 
fluorography. 
Chemical Cross-linking 
The second experimental approach we employed to study the 
nature of the interaction(s) between H1 and H2 was chemical 
cross-linking.  Two types of homobifunctional  reagents were 
used, DTSP and DFDNB, to determine if ill and H2 are non- 
covalently  associated  in  microsomal  membranes  and  thus 
can be chemically cross-linked to each other. In the study in 
Fig. 3, microsomes were treated for l  h at room temperature 
with 0  (lanes 1 and 2), 0.05 mM (lanes 3 and 4), 0.075  mM 
(lanes 5  and 6), and 0.10  mM (lanes  7and 8) DTSP;  subse- 
quently  they  were  solubilized  with detergent  and  immuno- 
adsorbed with anti-H1 serum (lanes 1, 3, 5, and 7), anti-H2 
serum  (lanes  2,  4,  6,  and  8),  or  control  serum  (data  not 
shown).  Higher molecular mass species of ",,93 and  148 kD 
were detected with anti-H1 or -H2 serum but not with con- 
trol serum. These 93- and  148-kD species were not detected 
in  the  non-cross-linked  material  immunoadsorbed  with 
anti-H1  (lane 1) or anti-H2  (lane 2).  Since the monomeric 
molecular masses of H1  and H2 are 46 and 50 kD,  respec- 
tively, these higher molecular mass species probably repre- 
sent dimeric and trimeric forms of the ASGP-R polypeptide 
chains. 
The reagent DTSP contains  a  disulfide  bond between the 
n-hydroxysuccinimide  reactive  groups  so  that  the  cross- 
linked  proteins  can  be  reduced  with  2-mercaptoethanol  to 
regenerate the monomeric forms. In Fig. 4, a sample equiva- 
lent  to  that  shown  in  Fig.  3,  lane  8  was  subjected  to  two 
dimensional  SDS-PAGE.  The first dimension  (see arrow at 
top)  was a  tube SDS-gel  run  in the absence of 2-mercapto- 
ethanol.  The tube gel was then equilibrated  in SDS-sample 
buffer containing 2 % 2-mercaptoethanol  and layered on top 
of a  slab gel  and  subjected  to  SDS-PAGE.  The dimer  and 
trimer species formed by DTSP comigrated with the mono- 
mer H2 after reduction  with 2-mercaptoethanol.  A  similar 
result  was  obtained  with  dimers  and  trimers  immunoad- 
sorbed with  anti-H1  antibody  (data not  shown). 
The efficiency of chemical cross-linking with DTSP (Fig. 
3) was too low to determine the composition of the dimer and 
trimer species.  To overcome this problem,  we tried a  more 
efficient,  but noncleavable cross-linking  reagent-DFDNB. 
In Fig. 5, microsomal membranes were isolated from HepG2 
cells  labeled  with  [35S]cysteine  for  20  h  and  subjected  to 
chemical cross-linking with DFDNB (lanes 3-11 ) or to mock 
cross-linking (lanes 1 and 2).  The membrane proteins were 
solubilized and subjected to immunoadsorption with anti-H1 
(lanes 1, 3-6), anti-H2 (lanes 2, 7-10) or control serum (lane 
//).  Antibody  complexes  were  eluted  from  the  Protein-A 
Sepharose by heating  for 5  min at  100~  in 50  ~tl of PBS, 
1% SDS,  and 2 mM dithiothreitol.  For lanes 1-3,  7, and 11, 
Figure 4. Two-dimensional SDS-PAGE of DTSP-cross-linked pro- 
teins that were immunoadsorbed with anti-H2 antibody.  HepG2 
cells were labeled for 20 h with [35S]cysteine and the microsomal 
membranes were cross-linked with 0.1 mM DTSP and subjected to 
immunoadsorption with anti-H2 antibody.  The antigen-antibody 
complexes were subjected to electrophoresis (arrow at top indicates 
direction of migration) on a tube gel under nonreducing conditions. 
The tube gel was then subjected to electrophoresis (arrow on the 
vertical axis indicates  direction) on an SDS-slab gel under reducing 
conditions. The numbered arrows, 1, 2, and 3, indicate  monomer, 
dimer, and trimer species, respectively. 
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cross-linking  are recognized by both anti-H1 and anti-H2 antibod- 
ies.  HepG2  cells  were  labeled  for 20  h  with  [35S]cysteine and 
microsomal membranes were treated  without (lanes  1 and 2)  or 
with (lanes 3-11) 1 mM DFDNB. The solubilized  membrane pro- 
teins  were immunoadsorbed with anti-H1  (lane  1, 3-6), anti-H2 
(lane 2,  7-10) or control serum (lane//).  A portion of these  im- 
munoadsorbed proteins was analyzed directly on SDS-PAGE (lanes 
1-3,  7,  and  //).  Denatured  antigen-antibody eluates  were read- 
sorbed with anti-H1 (lane 4 and 8), anti-H2 (lane 5 and 9) or con- 
trol  (lane  6 and  10) serum.  The immunoadsorbed proteins  were 
subjected  to SDS-PAGE on a 5-10%  polyacrylamide gradient  gel 
and then fluorography. The numbered  arrows,  1, 2, and 3, indicate 
monomer, dimer,  and trimer species,  respectively. 
the eluted samples were prepared for SDS-PAGE. Treatment 
of microsomal membranes with  1 mM DFDNB resulted in 
more efficient  formation of dimer  and  trimer  species  that 
were recognized by anti-H1  (lane 3) and anti-H2  (lane  7) 
antibodies  but not by control serum  (lane//). 
In order to elucidate the composition of the 93- and 148-kD 
species  observed  after  DFDNB  cross-linking,  individual 
dimer and trimer species were tested for immunoreactivity 
with  both  anti-HI  and  anti-H2  antibodies  (Fig.  5).  The 
e|uted and denatured  samples  that had first been adsorbed 
with  anti-H1  (lanes  4-6)  or  anti-H2  (lanes  8-10)  serum 
were diluted with 0.35  ml of immunoadsorption buffer, ad- 
justed to 2  mM oxidized glutathione,  and immunoadsorbed 
with anti-H1 (lanes 4 and 8), anti-H2 (lanes 5 and 9) or con- 
trol serum (lanes 6 and 10). The 93- and 148-kD cross-linked 
species that were first immunoadsorbed with anti-H1  anti- 
body  were  subsequently  recognized  by  anti-H2  antibody 
(Fig. 5, lane 5) as well as by anti-H1  (Fig. 5, lane 4).  Con- 
versely, the 93- and 148-kD species that were first immuno- 
adsorbed  with anti-H2 antibody were subsequently  recog- 
nized  by  anti-H1  antibody  (Fig.  5,  lane  8)  as  well  as  by 
anti-H2 (Fig. 5, lane 9). Importantly, the monomeric forms 
of H1 and H2 adsorbed initially by anti-H1 or anti-H2,  re- 
spectively,  were  not  recognized  by  the  opposite  antibody 
(lanes 5  and 8).  Readsorption with control serum (lanes  6 
and 10) shows that all of the antibody molecules used in the 
first  immunoadsorption  step  were  denatured  by boiling  in 
SDS  and  dithiothreitol.  These  results  provide further  evi- 
Figure  6.  Immunoblot  with  anti-H1  antibody.  HepG2  cell 
microsomal membrane proteins were treated without (lanes 1-3) or 
with  (lanes  5-7)  1 mM DFDNB. Solubilized  membrane proteins 
were immunoadsorbed with control (lanes I and 5), anti-H1 (lanes 
2 and 6), or anti-H2 (lanes 3 and 7) and subjected to SDS-PAGE. 
The  SDS-gel  was  blotted  onto  nitrocellulose  and  treated  with 
anti-HI  antibody  as  described  in  Materials  and  Methods.  ~4C- 
labeled  protein  standards  were  run  in  lane  4.  The  solid  arrows 
marked I, 2, and 3, indicate monomer, dimer, and trimer species, 
respectively.  The open arrow indicates  the position  of the 53-kD 
rabbit  IgG heavy chain. 
dence that H1 and H2 are associated in HepG2 membranes 
in a  hetero-oligomeric complex. 
To corroborate the results presented in Fig.  5,  we used a 
different  immunodetection  method  to  demonstrate  that  at 
least some dimer and trimer species formed after chemical 
cross-linking react with both anti-H1  and anti-H2 antibod- 
ies.  Microsomal membranes were prepared from confluent 
monolayers of HepG2 cells and subjected to chemical cross- 
linking  with  DFDNB  (Fig.  6,  lanes  5-7)  or  mock cross- 
linking  (Fig.  6,  lanes  1-3).  The  solubilized  proteins  were 
subjected to immunoadsorption with control serum (lanes 1 
and 5), anti-H1 (lanes 2 and 6), or anti-H2 (lanes 3 and 7) 
and then SDS-PAGE. The proteins fractionated by SDS-PAGE 
were transferred electrophoretically to a nitrocellulose mem- 
brane and then treated  with anti-H1  antibody as described 
in Materials and Methods. In lane 2, the 46-kD H1 monomer 
reacted with the anti-H1 antibody by the immunoblot proce- 
dure as expected. A trace amount of dimer (93 kD) was also 
observed in lane 2. The 53-kD heavy chain of rabbit immu- 
noglobulin  reacted  with  the  ~25I-Protein-A  and  thus,  was 
seen in varying amounts in every lane of the gel, as was one 
other nonspecific band.  Lanes 5-7 are the  DFDNB cross- 
The Journal of Cell Biology, Volume  106,  1988  1072 linked  samples.  The  anti-H1  immunoadsorbed  material 
(lane 6) contains 93- and 148-kD species that react with anti- 
H1  antibody by immunoblotting.  Therefore, each  species 
must contain at least one H1 polypeptide chain. The anti-H2 
immunoadsorbed material  (lane  7)  also contains 93- and 
148-kD  species that  react with  the  anti-H1  antibody and 
therefore, must contain both H1 and H2 polypeptides. Thus, 
the H1 and H2 ASGP-R proteins can be chemically cross- 
linked to each other in microsomal membranes.  The con- 
verse experiment, immunoblotting with anti-H2 antibody, 
could not be done because we do not have an anti-H2 anti- 
body that reacts with SDS-denatured H2 on an immunoblot. 
Minor  bands  were  detected  by  the  immunoadsorption/ 
immunoblot procedure that migrated as very high molecular 
species of 178, 213, and 280 kD (Fig. 6, lanes 6and 7). These 
could represent tetra-, penta-, and hexameric forms of the 
ASGP-R polypeptides, but we cannot rule out the possibility 
that they contain unrelated proteins cross-linked nonspecifi- 
cally to H1 and H2 polypeptides. 
Discussion 
Antibody-induced degradation and chemical cross-linking 
experiments demonstrate that the H1 and H2 ASGP-R poly- 
peptides must be associated in a hetero-oligomeric complex 
and therefore both polypeptides constitute the ASGP-R in 
HepG2 cells.  This result is in agreement with the cDNA 
transfection studies of McPhaul  and  Berg (17) on the  rat 
ASGP-R polypeptides and with similar results from this lab- 
oratory on the human ASGP-R polypeptides (Shia, M. A., 
and H.  E  Lodish, manuscript submitted for publication). 
First, a highly specific antiserum that recognizes the car- 
boxyl terminus of  ill caused a rapid and equal loss of  cellular 
H1 and H2 polypeptides. Similarly, an antiserum specific for 
the carboxyl terminus of H2 caused an equal loss of H1 and 
H2. Thus, over the time course of the experiment, most of 
the cell-associated H1  must be in a complex with H2, and 
vice-versa. Antibody-induced degradation, or in some cases, 
detergent insolubility has been observed for a  number of 
cell surface  receptors  and  macromolecules  including  the 
low-density lipoprotein receptor (1), the 215-kD mannose-6- 
phosphate receptor (8), and the ASGP-R (21). Schwartz et al. 
(21) have shown that anti-ASGP-R antibody added to intact 
HepG2 cells caused a specific and rapid degradation of im- 
munoreactive 46-kD ASGP-R. The polyclonal anti-ASGP-R 
antibody they used was raised against affinity-purified  human 
liver ASGP-R but appears to recognize only the 46-kD H1 
polypeptide. Thus, these investigators were analyzing only 
one component of the ASGP-R. For each of these receptors, 
and in this study, the effect of the antireceptor antibodies was 
shown to be specific because the antibodies did not cause 
degradation of other, nonrelated cell surface molecules nor 
did antibodies to unrelated cell surface molecules affect the 
receptor in question. 
In an experiment similar to that presented in Fig. 2 and Ta- 
ble I, O'Neill et al. (19) have reported recently that two dis- 
tinct cell surface molecules, the T-cell receptor and the L3T4 
molecule, form the binding site on C6VL/1 cells for its cog- 
nate retrovirus by demonstrating that incubation of C6VL/1 
cells with either anti-T-cell receptor antibody or anti-L3T4 
antibody causes a  specific loss of retrovirus binding sites. 
Hence, the composition of multicomponent cell surface re- 
ceptors can be elucidated, in part, by studying the effect of 
antibodies specific for one component on the cellular fate of 
the other polypeptide components. 
The results of our chemical cross-linking experiments sup- 
port the notion that the human ASGP-R is a hetero-oligomer 
because membrane-associated H1 and H2 can be chemically 
cross-linked to  each  other to  form  a  trimer.  Dimer  and 
trimer, but not monomer species that were initially immuno- 
adsorbed with anti-H1 serum, subsequently reacted with an 
anti-H2 antibody; similarly, dimers and trimers that were 
initially immunoreactive with anti-H2 serum, subsequently 
reacted with anti-HI antibody (Figs. 5 and 6). Although we 
have not determined the exact composition, we postulate that 
some of the trimers contain two H1 molecules and one H2 
molecule because H1 appears to be more abundant than H2 
in HepG2 cells.  It is possible,  however, that some cross- 
linked H1 homodimers and H1 homotrimers exist. The trimer 
is a minimum estimate of the true size of the ASGP-R in an 
intact HepG2 cell. Minor bands of 178, 213, and 280 kD were 
observed (Fig. 6, lanes 6 and 7) in cross-linked samples that 
might represent higher oligomeric forms of the ASGP-R. 
Schwartz  and  co-workers  (24)  reported  that  the  HepG2 
ASGP-R has a minimum functional size of 140,000 D  and 
postulated that the functional receptor is a tetramer of recep- 
tor polypeptides. 
Chemical cross-linking reagents have been used to study 
the association or interaction of various membrane bound 
proteins. Recently, Loeb and Drickamer (16) used chemical 
cross-linking with DFDNB to show that the detergent-solu- 
bilized chicken asialoagalactoglycoprotein-receptor, which 
is related to the ASGP-R, is a hexameric protein of six appar- 
ently identical  subunits.  When  the  DFDNB  reaction was 
carried out on membrane-bound receptor, only dimer and 
trimer species were observed. They attributed this difference 
to the fact that the high concentration of lipids and proteins 
in the membrane compete for the cross-linking reagent and 
therefore inhibit  hexamer  formation.  They proposed  that 
multiple sugar-binding sites clustered together in an oligo- 
meric  receptor would  endow  the  receptor with  the  high 
affinity binding activity that it does exhibit. 
Very recently, the rat ASGP-R polypeptides, RHL-1 and 
RHL-2/3,  were  subjected  to  the  same  types of chemical 
crosslinking experiments by Halberg et al. (10). They found 
that  when  homogeneous preparations  of RHL  containing 
RHL-1, RHL-2, and RHL-3 polypeptides were treated with 
DFDNB,  hexamers of RHL-1  and  hexamers  of RHL-2/3 
were formed. When the chemical crosslinking was carried 
out on rat liver microsomal membranes, RHL-I dimers and 
trimers were formed as well as RHL-2/3 dimers and trimers. 
They never observed RHL-1-RHL2/3 cross-linked species, 
and therefore concluded that the RHL-1 and RHL-2/3 poly- 
peptides represent separate populations of ASGP-Rs. These 
results are not consistent with our data since we have demon- 
strated  that  H1  can  be  chemically crosslinked  to  H2  in 
microsomal membranes (Figs.  5 and 6).  This discrepancy 
might be due to the fact that RHL-1 and RHL-2/3 polypep- 
tides are slightly different than their human counterparts, H1 
and H2. The amino acid sequences are very similar (18, 27) 
but not identical. In addition,  RHL preparations contain a 
third polypeptide, RHL-3, which is not observed in human 
ASGP-R preparations. RHL-3 might alter the structure of  the 
rat ASGP-R.  Another possibility is that RHL heterooligo- 
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abolished  assymetrically  an  epitope required  for antibody 
recognition.  In summary,  several  lines of evidence suggest 
that the human ASGP-R is made up of two distinct polypep- 
tide chains-H1 and H2. First, both H1 and H2 polypeptides 
were degraded when HepG2 cells were incubated with either 
anti-HI  or anti-H2  antibody  (Fig.  2).  Second, dimer and 
trimer  species  containing  H1  and  H2  polypeptides  were 
formed upon  chemical  crosslinking  (Figs.  5  and  6).  And 
finally,  cDNA  transfection  experiments  demonstrate  that 
expression  of both  HI  and  H2  is  required  to  reconstitute 
ASGP-R  activity  in murine  fibroblasts  (Shia  and  Lodish, 
submitted  for publication). We conclude that the H1 and H2 
polypeptides, associated in an oligomeric complex, form the 
human  ASGP-R. 
We thank Drs. J. Amara, E. J. Neufeld, and B. Thorens for critical reading 
of the manuscript and M,  Boucher  for excellent secretarial  assistance. 
Dr. Bischoff is a postdoctoral  fellow of the Helen Hay Whitney Founda- 
tion and Dr. Shia was supported  by a postdoctoral  fellowship from the Na- 
tional Institutes of Health (GM-10203). This research  was supported  in part 
by  National Institute  of Health grant GM-35012. 
Received for publication 24 September 1987, and in revised form 23 Novem- 
ber  198Z 
References 
I. Anderson, R. G, W.. M. S. Brown, U. Beisigel, J. L, Goldstein. 1982. Sur- 
face distribution  and  recycling of low density  lipoprotein  receptor  as 
visualized with anti-receptor antibodies.  J.  Cell Biol.  93:523-531. 
2. Ashwell, G., and J. Harford.  1982. Carbohydrate-specific receptors of the 
liver. Annu.  Rev,  Biochem.  51 :  531-554. 
3. Baenziger, J.  U,, and Y. Maynard.  1980. Human hepatic lectin. J.  BioL 
Chem,  255:4607-46t3. 
4. Barany, G., and R. B. Merrifield.  1979. The Peptides.  Vol. 2. E, Gross 
and S. J. Meinhoffer, editors. Academic Press, Inc,, New York.  1-284. 
5. Bischoff, J. and H. F. Lodish, 1987. Two asialoglycoprotein-receptor poly- 
peptides in human hepatoma cells. J.  Biol.  Chem,  262:11825-11832. 
6. Breitfeld, P. P., C, F, Simmons, Jr., G. J, Strous, H. J. Geuze, and A. L. 
Schwartz.  1985. Cell biology of the asialoglycoprotein-receptor system: 
a model for receptor-mediated endocytosis.  Int.  Rev.  QvtoL  97:47-95. 
7. Drickamer,  K., J. F, Mamon, G. Binns, and J. O. Leung.  1984. Primary 
structure of the rat liver asialogtycoprotein-receptor. J. Biol. Chem. 259: 
770-778. 
8. Gartung, C., T. Braukle, A. Hasilik, K. yon Figura.  1985. Internalization 
of blocking antibodies against mannose-6-phosphate specific receptors. 
EMBO (Eur.  Mol.  Biol.  Organ.) J.  4:1725-1730. 
9. Green, N., H. Alexander, A. Olson, S. Alexander, T. M. Shinnick, J. G. 
Sutcliffe, and R. A. Lerner.  1982. lmmunogenic structure of the influenza 
virus hemagglutinin.  Cell.  28:477-487. 
10.  Halberg, D. F., R. E. Wager,  D. C. Farrell,  J. Hildreth, M. S. Quesen- 
berry, J. A. Loeb, E. C. Holland, and K. Drickamer,  1987. Major and 
minor forms of the rat liver asialoglycoprotein-receptor are independent 
galactose binding proteins.  J,  Biol.  Chem.  262:9828-9838. 
11.  Holland, E. C., J. O. Leung, and K. Drickamer.  1984. Rat asialoglyco- 
protein  receptor  lacks  a  cleavable  NH2-terminal signal  sequence.  J. 
Biol.  Chem.  81:7338-7342. 
12, Hudgin, R. L, W, E, Pricer, Jr., G. Ashwell, R. J, Stockert, and A. G. 
Morell.  1974, The isolation and properties of a rabbit liver binding pro- 
tein specific for asialoglycoproteins.  J.  BioL  Chem.  249:5536-5543. 
13. Kawasaki, T., and G. Ashwell.  1976. Chemical and physical properties of 
an hepatic membrane protein that specifically binds asialoglycoproteins. 
J.  Biol.  Chem.  251:1296-1302. 
14.  Knowles, B. B.,  C. C.  Howe,  D. P.  Aden.  1980. Human hepatocellular 
carcinoma cell lines secrete the major plasma proteins and hepatitis B sur- 
face antigen. Science (Wash.  DC).  209:497-499. 
15,  Laemmli, U. K.  1970. Cleavage of structural proteins during assembly of 
the head of bacteriophage T4, Nature  (Lond.).  227:680-685. 
16.  Loeb, J. A,, and K, Drickamer.  1987. The chicken receptor for endocytosis 
of glycoproteins contains a cluster of/V-acetylglucosamine-binding sites. 
J.  Biol.  Chem.  262:3022-3029. 
17,  McPhaul,  M.,  and P.  Berg, 1986. Formation of functional asialoglyco- 
protein-receptor  after  transfection  with cDNAs  encoding  the  receptor 
proteins.  Proc.  Natl.  Acad.  Sci.  USA.  83:8863-8867. 
18.  McPhaul,  M.,  and  P.  Berg.  1987. Identification and characterization  of 
cDNA  clones encoding  two homologous  proteins  that  are  part of the 
asialoglycoprotein-receptor.  Mol.  Cell.  BioL  7:1841 - 1847. 
19.  O'Neill, H. C., M. S. McGrath, J. P. Allison, and I. L. Weissman.  1987. 
A subset of T cell receptors associated with L3T4 molecules mediates 
C6VL leukemia cell binding of its cognate retrovirus.  Cell, 49:143-151. 
20,  Patel, V. P., and H, F. Lodish~ 1987. A fibronectin matrix is required for 
differentiation of routine erythroleukemia cells into reticulocytes. J, Cell 
BioL  105:3105-3118~ 
21.  Schwartz,  A.  L., A.  Ciechanover,  S.  Merritt,  and A. Turkewitz.  1986. 
Antibody-induced receptor  loss. J.  Biol.  Chem.  261:15225-15232. 
22.  Schwartz, A. L., A. Marshak-Rothstein, D. Rup, and H. F. Lodish.  1981. 
Identification and quantification of the rat hepatocyte asialoglycoprotein 
receptor.  Proc.  Natl.  Acad.  Sci.  USA.  78:3348-3352, 
23.  Schwartz, A. L., and D. Rup. 1983. Biosynthesis of the asialoglycoprotein 
receptor. J.  Biol.  Chem.  258:11249-11255. 
24. Schwartz, A. L., C. J. Steer, E, S. Kempner.  1984. Functional size of the 
human asialoglycoprotein-receptor  as determined by radiation inactiva- 
tion. J.  Biol.  Chem.  259:12025-12029, 
25. Skinner, M. K., and M. D. Griswold.  1983. Fluorographic detection of ra- 
dioactivity in polyacrylamide gels with 2,5 diphenyloxazole in acetic acid 
and its comparison with existing procedures. Biochem. J. 209:281-284, 
26,  Spiess,  M.,  and  H.  F.  Lodish.  1985. Sequence  of  a  second  human 
asialoglycoprotein-receptor:  Conservation of two receptor genes during 
evolution.  Proc.  Natl.  Acad.  Sci.  USA.  82:6465-6469. 
27.  Spiess, M,, A. L. Schwartz, and H, F. Lodish.  1985. Sequence of human 
asialoglycoprotein-receptor  cDNA. J.  BioL  Chem.  260:1979-1982. 
28. Tanabe,  T., W.  E.  Pricer, Jr., and G.  Ashwell.  1979. Subcellular mem- 
brane topology and turnover of a rat hepatic binding protein specific for 
asialoglycoproteins.  J,  BioL  Chem.  254:1038-1043. 
29. Taylor, R. B., W. P. H, Duffus, M. C. Raft, and S, de Petris.  1971. Redis- 
tribution and pinocytosis of lymphocyte surface immunoglobulin mole- 
cules by anti-immunoglobulin molecule. Nat,  New Biol.  233:225-229. 
The Journal of Cell Biology, Volume  106, 1988  1074 